MIMS® Retrospective Chart Review

This is a post-market clinical follow-up, retrospective chart review of MIMS® surgical procedures conducted during time period between Sep 2023 and May 2025.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Open Angle Glaucoma Eye Diseases Glaucoma Glaucoma, Open-Angle Ocular Hypertension

Age range

40 year–85 year

Sex eligibility

All sexes

Study type

Observational

Primary location

S. Malayan Eye Center

Yerevan, Armenia

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Eye treated with MIMS® Device as a standalone procedure
MIMS® surgery was performed between 27 Sep 2023 and 30 April 2024

Treatment and study plan

Minimally Invasive Micro Sclerostomy

Device

The MIMS® procedure uses the proprietary MIMS® device, which creates a sclerostomy in the eye.

Other names: MIMS

Primary outcomes

Change in IOP from medicated baseline at 12 months post-MIMS® surgery

Time frame: Medicated baseline at 12 months post-MIMS® surgery
Change in the number of topical IOP-lowering medications from medicated baseline at 12 months post-MIMS® surgery

Time frame: Medicated baseline at 12 months post-MIMS® surgery
Success rate at 12 months post-MIMS® surgery

Time frame: 12 months post-MIMS® surgery

Study contacts

Contact information is provided by the study sponsor or research team.

Khan Lau, OD

CONTACT

[email protected]

8082862666

Sponsors and collaborators

Lead sponsor

Sanoculis Ltd

Industry

Registry information

Official study title

Minimally Invasive Micro Sclerostomy (MIMS®) Retrospective Chart Review

Important dates

Study start: 2025
Primary completion: 2026
Study completion: 2026
First posted: Sep 26, 2024
Registry last updated: Jan 10, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting